← Leaderboards
David Stroncek
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGene TherapyHematologic NeoplasmsT-LymphocyteCell TherapyDendritic CellsTransfusionProceduresMalignant NeoplasmsReagentCell PhysiologyAntigensAutoimmune DiseasesInstrumentCellular EngineeringScale UpB-LymphocytesLaboratoriesMarrowPatient OrientedResearch PersonnelLaboratory ResearchProductionCd19 Gene
Grant awards (30)
Development of novel cell and gene therapies$0
ZIA · FY2025 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2025 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2024 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2024 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2023 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2023 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2022 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2022 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2021 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2021 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2020 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2020 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2019 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2018 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2017 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2016 · CL · contact PI
Structure and Function Granulocyte Antigens$0
ZIA · FY2015 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2015 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2014 · CL · contact PI
Structure and Function Granulocyte Antigens$0
ZIA · FY2014 · CL · contact PI
Structure and Function Granulocyte Antigens$0
ZIA · FY2012 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2012 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2010 · CL · contact PI
Structure and Function Granulocyte Antigens$0
ZIA · FY2010 · CL · contact PI
Development of novel cell and gene therapies$0
ZIA · FY2009 · CL · contact PI
Structure and Function Granulocyte Antigens$0
ZIA · FY2009 · CL · contact PI
Development Of Methods For Ex Vivo Cultured And Immunologically And/or Geneticall$78,728
Z01 · FY2008 · CL · contact PI
Methods For Positive And Negative Selection Of Hematopoietic Progenitor Cells$39,364
Z01 · FY2008 · CL · contact PI
Ex Vivo Culture And Characterization Of Dendritic Cells For Clinical Immunotherap$39,364
Z01 · FY2008 · CL · contact PI
Development of novel cell and gene therapies$0
Z01 · FY2008 · CL · contact PI